Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Omicron
Covaxin booster enhances antibody response against COVID variants: Study
The study was conducted in January and the findings were published in the "Journal of Travel Medicine" on 24th March
We remain optimistic that Evusheld will retain its efficacy against Omicron variant
Dr Anil Kukreja, Vice President, Medical Affairs and Regulatory, AstraZeneca India, tells Akanki Sharma about Evusheld, which was…
Novel antibody helps block COVID transmission in cells, finds study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
US FDA authorises Eli Lilly’s COVID-19 antibody drug
The FDA authorised bebtelovimab for emergency use in patients with mild-to-moderate COVID-19 who are at high risk of progression…
DCGI gives nod to SII’s proposal to manufacture vaccine against omicron for test and analysis
Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, had put in an application to the DCGI on 6th January…
COVID vaccines induce robust protection against severe disease from Omicron
The research demonstrated that the vaccines induce this protection through cellular immunity or the production of protective…
Israel broadens eligibility for fourth shot of COVID vaccine
Earlier this month, Israel began offering the fourth jab to people over 60, on the condition that at least five months have passed…
US limits use of Regeneron and Eli Lilly COVID-19 antibody treatments amid Omicron spread
The Food and Drug Administration (FDA) said the treatments are currently not cleared for use in any US states or territories, but…
Omicron may not evade all monoclonal antibodies, lab study suggests
Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron